According to a recent report by Coherent Market Insights, the global Digital Musculoskeletal (MSK) Care Market is estimated ...

"City of Hope and MSK develop tool to predict CAR T therapy outcomes for NHL" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have announced progress on that front — they have developed a new therapy that uses stem cells to treat advanced Parkinson’s.

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 ...

Employers can easily plug athletic therapy into their benefits plans, says Levac. And despite offering added flexibility, ...

Read more in Nature. MSK researchers develop a new grading system to assess the risk of developing a common CAR T cell therapy side effect Thrombocytopenia, or low platelet count, is a common side ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...